Puremed Pharma Private Limited
About Puremed Pharma Private Limited
Data last updated:
Puremed Pharma Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 25 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U52311MH2016PTC272363. Its GSTIN is 27AAICP5158M1ZT (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Yashwant Gopalrao Lanjewar and Asha Yashwant Lanjewar.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at C/O. Rajesh Waghmare House No.5 Gopal Nagar, Nagpur, Maharashtra, India – 440022.
As per the financials filed for FY 2022, the company reported a revenue of ₹13.35 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹38,861 (net margin 2.9%) and EBITDA of ₹45,817 (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 19% over five years.
As per MCA filings, the company has open charges of ₹9.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Puremed Pharma Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O. Rajesh Waghmare House No.5 Gopal Nagar, Nagpur, Maharashtra, India – 440022
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Puremed Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Puremed Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Puremed Pharma Private Limited, buy the company report.
Financials of Puremed Pharma Private Limited
FY 2022 filings availablePuremed Pharma Private Limited reported revenue of ₹13.35 Lakh (up 15% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 15% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹45,817 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹38,861 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Puremed Pharma Private Limited, buy the company report.
Board of directors of Puremed Pharma Private Limited
Puremed Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yashwant Gopalrao Lanjewar | Director | 26 May 2021 | 5 Years 4 Months | Current |
| Asha Yashwant Lanjewar | Director | 25 Jan 2016 | 10 Years 8 Months | Current |
| Narayan Jaydev Balpande | Director | 25 Jan 2016 | 10 Years 8 Months | Current |
Peer comparison
Puremed Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Expius Exports Private Limited | ₹13.35 Lakh (FY 2020) | -44.0% | Sundargarh, Odisha, India | |||
| Digiciti Online Imc (OPC) Private Limited | ₹13.35 Lakh (FY 2021) | -30.0% | Chandigarh, India | |||
| Rasili Enterprises Private Limited | ₹13.35 Lakh (FY 2024) | -64.0% | New Delhi, Delhi, India | |||
| Jitendra Sports Private Limited | ₹13.35 Lakh (FY 2024) | 109.0% | Vadodara, Gujarat, India | |||
| Lahthi Trends Private Limited | ₹13.35 Lakh (FY 2024) | Kolkata, West Bengal, India | ||||
| Puremed Pharma Private Limitedthis company | ₹13.35 Lakh (FY 2022) | ₹38,861 | 2.9% | 15.0% | Nagpur, Maharashtra, India | |
| Vira Biologicals Private Limited | ₹13.34 Lakh (FY 2023) | Hyderabad, Telangana, India | ||||
| B.S. Sethi and Sons Motors Private Limited | ₹13.34 Lakh (FY 2019) | 3.0% | New Delhi, Delhi, India | |||
| Novatech Energie Systech Private Limited | ₹13.34 Lakh (FY 2024) | 2417.0% | Vadodara, Gujarat, India | |||
| Trillion Tradelink Private Limited | ₹13.34 Lakh (FY 2025) | -3.0% | Kolkata, West Bengal, India | |||
| Kurane Enterprises Private Limited | ₹13.34 Lakh (FY 2019) | 567.0% | Miraj, Maharashtra, India |
To see the full peer comparison of Puremed Pharma Private Limited, buy the company report.
Auditor
Puremed Pharma Private Limited is audited by VNV & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VNV & CO. | FY 2017 | AANFG2446B |
Shareholding
The shareholding of Puremed Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Puremed Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jun 2016 | 100033975 | Bank of India | ₹9.5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Puremed Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Puremed Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Puremed Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICP5158M1ZT | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Puremed Pharma Private Limited, buy the company report.
Recent activity
Puremed Pharma Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Yashwant Gopalrao Lanjewar was appointed as Director on 26 May 2021.
Frequently asked questions
Puremed Pharma is an active private limited company based in Nagpur, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 25 January 2016 (10+ years old) and is registered under CIN U52311MH2016PTC272363.
Puremed Pharma has 3 current directors:
- Yashwant Gopalrao Lanjewar - Director
- Asha Yashwant Lanjewar - Director
- Narayan Jaydev Balpande - Director
The latest financial statements of Puremed Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Puremed Pharma is 27AAICP5158M1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Puremed Pharma is U52311MH2016PTC272363. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Puremed Pharma was incorporated on 25 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Puremed Pharma by revenue are Expius Exports Private Limited, Digiciti Online Imc (OPC) Private Limited, Rasili Enterprises Private Limited, Jitendra Sports Private Limited, Lahthi Trends Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Yashwant Gopalrao Lanjewar was appointed as Director on 26 May 2021. Asha Yashwant Lanjewar was appointed as Director on 25 Jan 2016. Narayan Jaydev Balpande was appointed as Director on 25 Jan 2016.
The registered office of Puremed Pharma is at CO. Rajesh Waghmare House No.5 Gopal Nagar, Nagpur, Maharashtra, India – 440022.
Puremed Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.
Puremed Pharma has open charges of ₹9.5 Lakh and no satisfied charges on record as per latest MCA filings.